etisulergine has been researched along with mesulergine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinne, UK | 2 |
| Ståhle, L; Ungerstedt, U | 1 |
| Jensen, I; Pakkenberg, H | 1 |
| Reynolds, GP; Riederer, P | 1 |
1 trial(s) available for etisulergine and mesulergine
| Article | Year |
|---|---|
Treatment of Parkinson's disease with the ergoline derivatives CQ 32-084 and CU 32-085.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects | 1983 |
4 other study(ies) available for etisulergine and mesulergine
| Article | Year |
|---|---|
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.
Topics: Animals; Bromocriptine; Ergolines; Exploratory Behavior; Habituation, Psychophysiologic; Male; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.
Topics: Brain; Bromocriptine; Ergolines; Humans; Kinetics; Lisuride; Receptors, Dopamine; Spiperone | 1981 |